An update on treatment options for interstitial cystitis

Area of Science:

• Urology
• Pain Medicine
• Gastroenterology

Background:

• Interstitial cystitis or bladder pain syndrome (IC/BPS) is a chronic condition characterized by pelvic pain and bladder discomfort.
• Current treatment paradigms primarily address symptom management due to limited understanding of underlying pathophysiologies.
• Emerging evidence suggests IC/BPS has a multifactorial etiology involving systemic components beyond the bladder.

Purpose of the Study:

• To review current treatment strategies for IC/BPS.
• To highlight the limitations of existing evidence-based approaches.
• To emphasize the need for further research into the disease's complex mechanisms.

Main Methods:

• Review of existing literature and clinical guidelines on IC/BPS treatment.
• Analysis of traditional and emerging therapeutic approaches.
• Discussion of the role of conservative, pharmacological, and invasive interventions.

Main Results:

• Treatment strategies for IC/BPS traditionally focus on the bladder, often yielding symptomatic relief rather than addressing root causes.
• A personalized, stepwise approach is recommended, starting with behavioral modifications and progressing to oral medications, intravesical instillations, and more invasive options.
• Optimal treatment remains challenging due to the multifaceted nature of IC/BPS and limited etiological understanding.

Conclusions:

• Further investigation into the etiopathogenesis of IC/BPS, considering subgroup variations and central/peripheral interactions, is crucial.
• A deeper understanding of the disease mechanisms is necessary to improve treatment efficacy and patient management.
• Personalized and progressive treatment strategies, informed by ongoing research, are key to managing IC/BPS effectively.